Related Experiment Video
Updated: Apr 27, 2026

06:50
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
2.8K
Context-aware multi-property antibody predictor: a novel framework integrating text and protein language models
Luca Giancardo1, Melih Yilmaz2, Edward Lee2
1Life Sciences, Amazon Web Services, Seattle, WA, USA. lugianca@amazon.com.
NPJ Systems Biology and Applications
|April 26, 2026
Summary
This study introduces a new AI model for antibody development, improving prediction accuracy for therapeutic candidates. The multimodal architecture efficiently adapts to new data, overcoming challenges in antibody design.
Area of Science:
- Computational Biology
- Machine Learning in Drug Discovery
- Protein Engineering
Background:
- Machine learning (ML) accelerates antibody development via in silico models for therapeutic candidate identification.
- Challenges include adapting property predictors to specific assays with limited data, batch effects causing bias, and high assay costs.
- Efficient prediction of unseen properties is crucial for cost-effective antibody development.
Purpose of the Study:
- To introduce a novel multimodal architecture for context-conditioned multi-property prediction in antibody development.
- To enable efficient adaptation to laboratory-specific assays and mitigate batch effects without retraining.
- To improve the accuracy and efficiency of predicting antibody developability properties.
Main Methods:
- Developed a novel multimodal architecture with specialized tokenization and embedding projection.
- Integrated text and protein language models (pLM) with a context-conditioned learning strategy.
- Utilized 876,898 antibody heavy chain sequences, including simulated batch effects, for training and validation.
Main Results:
- Achieved Spearman's ρ > 0.8 across multiple developability properties, demonstrating high prediction accuracy.
- Significantly outperformed fine-tuned multimodal large language models (LLMs).
- Demonstrated the model's ability to leverage correlations between properties for enhanced prediction.
Conclusions:
- The proposed multimodal architecture effectively addresses key challenges in antibody development, including data scarcity and batch effects.
- The framework enables context-conditioned multi-property prediction and inference-time adaptation without retraining.
- This approach offers a powerful tool for accelerating the identification and optimization of therapeutic antibody candidates.
More Related Videos
Related Concept Videos
Antibody Structure
51.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
51.6K
Antibody Structure
12.0K
12.0K
Antibody Actions
3.9K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.9K
Antibody Structure and Classes
7.6K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
7.6K
Immunoprecipitation
5.5K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.5K
Antigens Involved in Adaptive Immunity
1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K

